MedTrace Logo

Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass.

NCT01308554 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-03-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether injection of bupivacaine into the TAP is effective in the treatment of post operative pain after laparoscopic gastric bypass

Conditions

Interventions

DRUG

Placebo: sterile normal saline

Bilateral TAP block using 20 ml of normal sterile saline per block.

DRUG

Marcaine

Study group will receive a bilateral TAP block using 20 ml of 0,25% Marcain on each side.

Sponsors & Collaborators

  • Medtronic - MITG

    collaborator INDUSTRY

  • Funch-Jensen, Peter, M.D., D.M.Sc.

    lead INDIV

Principal Investigators

  • Peter Funch-Jensen, D.M.Sc. · Privathospital Hamlet Aarhus, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01308554 on ClinicalTrials.gov